← Back to Clinical Trials
Recruiting NCT06840106

NCT06840106 Nasal Steam Therapy for Post-extubation Respiratory Events

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06840106
Status Recruiting
Phase
Sponsor Ilsan Cha hospital
Condition Thyroid Cancer
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2025-02-18
Primary Completion 2027-12-31

Trial Parameters

Condition Thyroid Cancer
Sponsor Ilsan Cha hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 66
Sex ALL
Min Age 19 Years
Max Age 69 Years
Start Date 2025-02-18
Completion 2027-12-31
Interventions
Nasal steam therapyRoutine management strategy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The effect of symptom improvement of nasal steam strategy compared to routine management strategy for upper respiratory symptoms occurring after endotracheal intubation in patients aged 19 years or older who underwent surgical removal under anesthesia requiring endotracheal intubation was evaluated by the difference in the results of Wisconsin Upper Respiratory Symptom Survey

Eligibility Criteria

Inclusion Criteria: * Age of 19 to 69 years * Those who underwent surgical removal of the thyroid gland under endotracheal intubation due to a thyroid tumor * American Society of Anesthesiologists (ASA) status I or II * Those who developed upper respiratory symptoms after surgery ⑤ Voluntarily decided to participate in this clinical trial and signed the informed consent form Exclusion criteria: * Those diagnosed with symptomatic gastroesophageal reflux disease * Chronic cough lasting for more than 3 months prior to surgery, including bronchial asthma and chronic obstructive pulmonary disease (COPD) * Those who developed other respiratory infections within the past month ④ Those who are taking or are required to take other medications that may interfere with the interpretation of the treatment effect or results * Those who are scheduled to undergo additional major treatments such as reoperation, chemotherapy, and radiotherapy during the clinical trial period ⑥ Pregnant women, breastfeed

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology